Cargando…
The Cholinergic Pathways in Inflammation: A Potential Pharmacotherapeutic Target for COPD
In COPD, the activity of the cholinergic system is increased, which is one of the reasons for the airflow limitation caused by the contraction of airway smooth muscles. Therefore, blocking the contractive actions with anticholinergics is a useful therapeutic intervention to reduce the airflow limita...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287026/ https://www.ncbi.nlm.nih.gov/pubmed/30559673 http://dx.doi.org/10.3389/fphar.2018.01426 |